Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967132 · ClinicalTrials.gov registry record · NA
Growth and Tolerance of Infants Fed Milk-Based Infant Formula
A NA study of Gastrointestinal Tolerance, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 189
- Enrollment target
- 19
- Study locations
NCT03967132: Completed NA study of Gastrointestinal Tolerance, sponsored by Abbott Nutrition.
NCT03967132 is a NA study of Gastrointestinal Tolerance that has completed, run by Abbott Nutrition. The registered enrollment target is 189 participants, above the 161-participant average among 4 other Gastrointestinal Tolerance trials with a reported enrollment target (17% higher). The trial reports 19 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03967132, a NA study of Gastrointestinal Tolerance, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 189 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this study is to evaluate growth and tolerance of healthy term infants fed an experimental milk-based infant formula with oligosaccharides compared to a control milk-based infant formula.
Primary Outcome
Weight gain per day
Conditions Studied
Interventions
- OTHER Experimental Infant Formula
- OTHER Control Infant Formula
- OTHER Reference Group
Study Locations (19)
Texas
- ARC Clinical Research at Wilson Parke - Austin
- Ventavia Research Group, LLC - Fort Worth
- Ventavia Research Group - Houston
- Ventavia Research Group, LLC 3078 - Keller
- Kagan Pediatrics - HD Research Corporation - Pearland
- Plano Pediatrics - ACRC Trials - Plano
Florida
- Phoenix Medical Research LLC - Miami
- University Clinical Research-Deland, LLC a/b/a Accel Clinical Research - Orlando
Kentucky
- Michael W. Simon, M.D., PSC - Nicholasville
- Springs Medical Research - Owensboro
Ohio
- Institute of Clinical Research, LLC - Mentor
- The Cleveland Pediatric Research Center, LLC - Middleburg Heights
Tennessee
- Holston Medical Group - Kingsport
- Midsouth Center for Clinical Research - Memphis
Arizona
- Watching Over Mothers & Babies - Tucson
California
- Pediatric Medical Associates - Sacramento
Connecticut
- Norwich Pediatric Group, P.C. - Norwich
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2019-06-08 |
| Est. Completion | 2020-05-29 |
| Phase | NA |
What the finished NCT03967132 record still lists
NCT03967132 is an interventional study that assigns participants to a tested intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap, above the 161-participant average among 4 other Gastrointestinal Tolerance trials with a reported enrollment target (17% higher).
The record links to 1 condition, with Gastrointestinal Tolerance appearing as the primary indexed condition, and to 3 interventions - of which Experimental Infant Formula is the first listed.
NCT03967132 lists 19 locations in 10 states (Texas, Florida, Kentucky).
Frequently Asked Questions
What is clinical trial NCT03967132 about?
NCT03967132 is a clinical study titled "Growth and Tolerance of Infants Fed Milk-Based Infant Formula". The purpose of this study is to evaluate growth and tolerance of healthy term infants fed an experimental milk-based infant formula with oligosaccharides compared to a control milk-based infant formula.
What is the current status of trial NCT03967132?
This trial is currently completed. It is a NA study. The enrollment target is 189 participants. The study started on 2019-06-08. Estimated completion is 2020-05-29.
What conditions does trial NCT03967132 study?
This clinical trial studies the following conditions: Gastrointestinal Tolerance.
What interventions are being tested in trial NCT03967132?
The interventions under investigation include: Experimental Infant Formula (OTHER), Control Infant Formula (OTHER), Reference Group (OTHER).
Who is sponsoring clinical trial NCT03967132?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03967132 being conducted?
This trial has 19 study locations across Arizona, California, Connecticut, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Tolerance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02734537 · 189 participants · Phase 2
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- NCT05058651 · 189 participants · Phase 2
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- NCT05673408 · 189 participants
NIBP Validation Study
- NCT05994209 · 189 participants · Phase 1
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI